Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.1 (
asparaginase
)
2,695
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Over the recent years glutaminase free
L-asparaginase
has gained more importance due to better therapeutic properties for treatment of acute lymphoblastic leukemia. Actinomycetes are known for
L-asparaginase
activity. In the current study, 80 actinomycetes were isolated from various soil habitats by serial dilution technique. Presence of
L-asparaginase
was investigated in a total of 240 actinomycetes by tubed agar method using modified M-9 medium. A total of 165 actinomycetes were found positive for
L-asparaginase
activity. Among these, 57 actinomycetes producing larger zones of L-asparagine hydrolysis were further screened for their capacity to produce glutaminase-free
L-asparaginase
. Four L-glutaminase-free actinomycetes were found to be potential
L-asparaginase
producers. These actinomycetes were identified as Streptomyces cyaneus (
SAP
1287, CFS 1560), S. exfoliates (CFS 1557) and S. phaeochromogenes (GS 1573) on the basis of morphological and biochemical identification studies. Maximum
L-asparaginase
activity (19.2 Uml(-1)) was observed in culture filtrate of S. phaeochromogenes under submerged fermentation. Results indicate that S. phaeochromogenes could be a potential source of glutaminase free
L-asparaginase
for commercial purpose. To the best of our knowledge, this is the first report on production of glutaminase free
L-asparaginase
from S. cyaneus, S. exfoliatus and S. phaeochromogenes.
...
PMID:Isolation and identification of actinomycetes for production of novel extracellular glutaminase free L-asparaginase. 2674 23